Motley FoolTop Gene-Editing Stocks for Long-Term InvestorsMotley FoolEditas owns the license to a group of patents for CRISPR-Cas9 and CRISPR-Cpf1 from the Broad Institute and Harvard College. CRISPR Therapeutics and Intellia licensed patents from the … Continue reading
FDA Approves CAR-T Cell Therapy for Diffuse Large B-Cell LymphomaCuretoday.comThe Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) – a CAR-T cell therapy – for the treatment of adult patients who have relapsed or refractory diffus… Continue reading
Mainline Today |
Three Immunotherapies for Long-Term Relief from Allergies
Mainline Today Plus, OTC medicines don’t treat the underlying causes and can lead to undesirable side effects like sleeplessness, nervousness, drowsiness, increased blood pressure, headaches, dry mouth, constipation and blurred vision. The experts at Allergy & Asthma … |
Mainline Today |
Three Immunotherapies for Long-Term Relief from Allergies
Mainline Today Plus, OTC medicines don’t treat the underlying causes and can lead to undesirable side effects like sleeplessness, nervousness, drowsiness, increased blood pressure, headaches, dry mouth, constipation and blurred vision. The experts at Allergy & Asthma … |